208 related articles for article (PubMed ID: 24976143)
1. Discovery of methyl 4'-methyl-5-(7-nitrobenzo[c][1,2,5]oxadiazol-4-yl)-[1,1'-biphenyl]-3-carboxylate, an improved small-molecule inhibitor of c-Myc-max dimerization.
Chauhan J; Wang H; Yap JL; Sabato PE; Hu A; Prochownik EV; Fletcher S
ChemMedChem; 2014 Oct; 9(10):2274-2285. PubMed ID: 24976143
[TBL] [Abstract][Full Text] [Related]
2. 3JC48-3 (methyl 4'-methyl-5-(7-nitrobenzo[c][1,2,5]oxadiazol-4-yl)-[1,1'-biphenyl]-3-carboxylate): a novel MYC/MAX dimerization inhibitor reduces prostate cancer growth.
Shukla S; Fletcher S; Chauhan J; Chalfant V; Riveros C; Mackeyev Y; Singh PK; Krishnan S; Osumi T; Balaji KC
Cancer Gene Ther; 2022 Nov; 29(11):1550-1557. PubMed ID: 35440696
[TBL] [Abstract][Full Text] [Related]
3. In vitro cytotoxicity and in vivo efficacy, pharmacokinetics, and metabolism of 10074-G5, a novel small-molecule inhibitor of c-Myc/Max dimerization.
Clausen DM; Guo J; Parise RA; Beumer JH; Egorin MJ; Lazo JS; Prochownik EV; Eiseman JL
J Pharmacol Exp Ther; 2010 Dec; 335(3):715-27. PubMed ID: 20801893
[TBL] [Abstract][Full Text] [Related]
4. Design and properties of a Myc derivative that efficiently homodimerizes.
Soucek L; Helmer-Citterich M; Sacco A; Jucker R; Cesareni G; Nasi S
Oncogene; 1998 Nov; 17(19):2463-72. PubMed ID: 9824157
[TBL] [Abstract][Full Text] [Related]
5. Pharmacophore identification of c-Myc inhibitor 10074-G5.
Yap JL; Wang H; Hu A; Chauhan J; Jung KY; Gharavi RB; Prochownik EV; Fletcher S
Bioorg Med Chem Lett; 2013 Jan; 23(1):370-4. PubMed ID: 23177256
[TBL] [Abstract][Full Text] [Related]
6. X-ray structures of Myc-Max and Mad-Max recognizing DNA. Molecular bases of regulation by proto-oncogenic transcription factors.
Nair SK; Burley SK
Cell; 2003 Jan; 112(2):193-205. PubMed ID: 12553908
[TBL] [Abstract][Full Text] [Related]
7. Small-molecule perturbation of competing interactions between c-Myc and Max.
Follis AV; Hammoudeh DI; Daab AT; Metallo SJ
Bioorg Med Chem Lett; 2009 Feb; 19(3):807-10. PubMed ID: 19114306
[TBL] [Abstract][Full Text] [Related]
8. Max: a helix-loop-helix zipper protein that forms a sequence-specific DNA-binding complex with Myc.
Blackwood EM; Eisenman RN
Science; 1991 Mar; 251(4998):1211-7. PubMed ID: 2006410
[TBL] [Abstract][Full Text] [Related]
9. Preferential heterodimeric parallel coiled-coil formation by synthetic Max and c-Myc leucine zippers: a description of putative electrostatic interactions responsible for the specificity of heterodimerization.
Lavigne P; Kondejewski LH; Houston ME; Sönnichsen FD; Lix B; Skyes BD; Hodges RS; Kay CM
J Mol Biol; 1995 Dec; 254(3):505-20. PubMed ID: 7490766
[TBL] [Abstract][Full Text] [Related]
10. The Max b-HLH-LZ can transduce into cells and inhibit c-Myc transcriptional activities.
Montagne M; Beaudoin N; Fortin D; Lavoie CL; Klinck R; Lavigne P
PLoS One; 2012; 7(2):e32172. PubMed ID: 22384171
[TBL] [Abstract][Full Text] [Related]
11. Perturbation of the c-Myc-Max protein-protein interaction via synthetic α-helix mimetics.
Jung KY; Wang H; Teriete P; Yap JL; Chen L; Lanning ME; Hu A; Lambert LJ; Holien T; Sundan A; Cosford ND; Prochownik EV; Fletcher S
J Med Chem; 2015 Apr; 58(7):3002-24. PubMed ID: 25734936
[TBL] [Abstract][Full Text] [Related]
12. The leucine zippers of the HLH-LZ proteins Max and c-Myc preferentially form heterodimers.
Muhle-Goll C; Nilges M; Pastore A
Biochemistry; 1995 Oct; 34(41):13554-64. PubMed ID: 7577944
[TBL] [Abstract][Full Text] [Related]
13. Analysis of the Myc and Max interaction specificity with lambda repressor-HLH domain fusions.
Marchetti A; Abril-Marti M; Illi B; Cesareni G; Nasi S
J Mol Biol; 1995 May; 248(3):541-50. PubMed ID: 7752223
[TBL] [Abstract][Full Text] [Related]
14. Selective inhibition of c-Myc/Max dimerization and DNA binding by small molecules.
Kiessling A; Sperl B; Hollis A; Eick D; Berg T
Chem Biol; 2006 Jul; 13(7):745-51. PubMed ID: 16873022
[TBL] [Abstract][Full Text] [Related]
15. Thermodynamics of protein-protein interactions of cMyc, Max, and Mad: effect of polyions on protein dimerization.
Banerjee A; Hu J; Goss DJ
Biochemistry; 2006 Feb; 45(7):2333-8. PubMed ID: 16475822
[TBL] [Abstract][Full Text] [Related]
16. Low molecular weight inhibitors of Myc-Max interaction and function.
Yin X; Giap C; Lazo JS; Prochownik EV
Oncogene; 2003 Sep; 22(40):6151-9. PubMed ID: 13679853
[TBL] [Abstract][Full Text] [Related]
17. Myc-Max heterodimers activate a DEAD box gene and interact with multiple E box-related sites in vivo.
Grandori C; Mac J; Siëbelt F; Ayer DE; Eisenman RN
EMBO J; 1996 Aug; 15(16):4344-57. PubMed ID: 8861962
[TBL] [Abstract][Full Text] [Related]
18. Visualization of Myc/Max/Mad family dimers and the competition for dimerization in living cells.
Grinberg AV; Hu CD; Kerppola TK
Mol Cell Biol; 2004 May; 24(10):4294-308. PubMed ID: 15121849
[TBL] [Abstract][Full Text] [Related]
19. Mmip1: a novel leucine zipper protein that reverses the suppressive effects of Mad family members on c-myc.
Gupta K; Anand G; Yin X; Grove L; Prochownik EV
Oncogene; 1998 Mar; 16(9):1149-59. PubMed ID: 9528857
[TBL] [Abstract][Full Text] [Related]
20. A novel inhibitor L755507 efficiently blocks c-Myc-MAX heterodimerization and induces apoptosis in cancer cells.
Singh A; Kumar A; Kumar P; Nayak N; Bhardwaj T; Giri R; Garg N
J Biol Chem; 2021 Jul; 297(1):100903. PubMed ID: 34157284
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
